These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 14673720

  • 1. Symptomatic and endoscopic outcome of heartburn 3-4.5 years after starting lansoprazole therapy: a prospective study of 142 patients.
    Abu Farsakh N.
    J Gastroenterol; 2003; 38(11):1042-8. PubMed ID: 14673720
    [Abstract] [Full Text] [Related]

  • 2. Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs.
    Inadomi JM, McIntyre L, Bernard L, Fendrick AM.
    Am J Gastroenterol; 2003 Sep; 98(9):1940-4. PubMed ID: 14499769
    [Abstract] [Full Text] [Related]

  • 3. Management of heartburn in a large, randomized, community-based study: comparison of four therapeutic strategies.
    Howden CW, Henning JM, Huang B, Lukasik N, Freston JW.
    Am J Gastroenterol; 2001 Jun; 96(6):1704-10. PubMed ID: 11419818
    [Abstract] [Full Text] [Related]

  • 4. Comparing lansoprazole and omeprazole in onset of heartburn relief: results of a randomized, controlled trial in erosive esophagitis patients.
    Richter JE, Kahrilas PJ, Sontag SJ, Kovacs TO, Huang B, Pencyla JL.
    Am J Gastroenterol; 2001 Nov; 96(11):3089-98. PubMed ID: 11721754
    [Abstract] [Full Text] [Related]

  • 5. Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials.
    Peura DA, Kovacs TO, Metz DC, Siepman N, Pilmer BL, Talley NJ.
    Am J Med; 2004 Jun 01; 116(11):740-8. PubMed ID: 15144910
    [Abstract] [Full Text] [Related]

  • 6. Daily low-dose versus alternate day full-dose lansoprazole in the maintenance treatment of reflux esophagitis.
    Baldi F, Morselli-Labate AM, Cappiello R, Ghersi S, Italian Lansoprazole Study Group.
    Am J Gastroenterol; 2002 Jun 01; 97(6):1357-64. PubMed ID: 12094850
    [Abstract] [Full Text] [Related]

  • 7. Treatment of patients with heartburn without endoscopic evaluation: on-demand treatment after effective continuous administration of lansoprazole 15 mg.
    Bigard MA, Genestin E.
    Aliment Pharmacol Ther; 2005 Oct 01; 22(7):635-43. PubMed ID: 16181303
    [Abstract] [Full Text] [Related]

  • 8. Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study.
    Armstrong D, Veldhuyzen van Zanten SJ, Barkun AN, Chiba N, Thomson AB, Smyth S, Sinclair P, Chakraborty B, White RJ, CADET-HR Study Group.
    Aliment Pharmacol Ther; 2005 May 15; 21(10):1189-202. PubMed ID: 15882239
    [Abstract] [Full Text] [Related]

  • 9. The effect of over-the-counter ranitidine 75 mg on night-time heartburn in patients with erosive oesophagitis on daily proton pump inhibitor maintenance therapy.
    Vakil N, Guda N, Partington S.
    Aliment Pharmacol Ther; 2006 Mar 01; 23(5):649-53. PubMed ID: 16480404
    [Abstract] [Full Text] [Related]

  • 10. What do heartburn sufferers expect from proton pump inhibitors when prescribed for the first time?
    Kamolz T, Pointner R.
    Minerva Gastroenterol Dietol; 2004 Jun 01; 50(2):143-7. PubMed ID: 15722984
    [Abstract] [Full Text] [Related]

  • 11. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL, Huang B, Amer F, Christopoulos NG.
    Clin Ther; 2004 Oct 01; 26(10):1637-43. PubMed ID: 15598480
    [Abstract] [Full Text] [Related]

  • 12. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC, Chu KM, Hui WM, Wong BC, Hu WH, Wong WM, Chan AO, Wong J, Lam SK.
    Am J Med; 2005 Nov 01; 118(11):1271-8. PubMed ID: 16271912
    [Abstract] [Full Text] [Related]

  • 13. Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence.
    Cooper BT, Chapman W, Neumann CS, Gearty JC.
    Aliment Pharmacol Ther; 2006 Mar 15; 23(6):727-33. PubMed ID: 16556174
    [Abstract] [Full Text] [Related]

  • 14. Heartburn severity does not predict disease severity in patients with erosive esophagitis.
    Fennerty MB, Johnson DA.
    MedGenMed; 2006 Apr 06; 8(2):6. PubMed ID: 16926745
    [Abstract] [Full Text] [Related]

  • 15. Lansoprazole overutilization: methods for step-down therapy.
    Pohland CJ, Scavnicky SA, Lasky SS, Good CB.
    Am J Manag Care; 2003 May 06; 9(5):353-8. PubMed ID: 12744297
    [Abstract] [Full Text] [Related]

  • 16. Maintenance of heartburn relief after step-down from twice-daily proton pump inhibitor to once-daily dexlansoprazole modified release.
    Fass R, Inadomi J, Han C, Mody R, O'Neil J, Perez MC.
    Clin Gastroenterol Hepatol; 2012 Mar 06; 10(3):247-53. PubMed ID: 22155561
    [Abstract] [Full Text] [Related]

  • 17. Nocturnal acid breakthrough in children with reflux esophagitis taking proton pump inhibitors.
    Pfefferkorn MD, Croffie JM, Gupta SK, Molleston JP, Eckert GJ, Corkins MR, Fitzgerald JF.
    J Pediatr Gastroenterol Nutr; 2006 Feb 06; 42(2):160-5. PubMed ID: 16456408
    [Abstract] [Full Text] [Related]

  • 18. Helicobacter pylori infection influences symptomatic response to anti-secretory therapy in patients with GORD--crossover comparative study with famotidine and low-dose lansoprazole.
    Adachi K, Hashimoto T, Komazawa Y, Mihara T, Furuta K, Fujishiro H, Ishihara S, Amano Y, Hattori S, Kinoshita Y.
    Dig Liver Dis; 2005 Jul 06; 37(7):485-90. PubMed ID: 15975534
    [Abstract] [Full Text] [Related]

  • 19. What is the best pharmacologic approach to managing moderate to severe heartburn?
    Melton ST, Cimmino A.
    J Fam Pract; 2001 Oct 06; 50(10):839. PubMed ID: 11674880
    [No Abstract] [Full Text] [Related]

  • 20. Psychological factors as a predictor of treatment response in patients with heartburn: a pooled analysis of clinical trials.
    Wiklund I, Carlsson R, Carlsson J, Glise H.
    Scand J Gastroenterol; 2006 Mar 06; 41(3):288-93. PubMed ID: 16497615
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.